User menu

IRS1 regulation by Wnt/beta-catenin signaling and varied contribution of IRS1 to the neoplastic phenotype.

Bibliographic reference Bommer, Guido ; Feng, Ying ; Iura, Ayaka ; Giordano, Thomas J ; Kuick, Rork ; et. al. IRS1 regulation by Wnt/beta-catenin signaling and varied contribution of IRS1 to the neoplastic phenotype.. In: The Journal of biological chemistry, Vol. 285, no. 3, p. 1928-38 (2010)
Permanent URL
  1. Moon Randall T., Kohn Aimee D., Ferrari Giancarlo V. De, Kaykas Ajamete, WNT and β-catenin signalling: diseases and therapies, 10.1038/nrg1427
  2. Slattery, Cancer Epidemiol. Biomark. Prev., 13, 1206 (2004)
  3. Cristofanelli Barbara, Valentinis Barbara, Soddu Silvia, Rizzo Maria Giulia, Marchetti Alessandra, Bossi Gianluca, Morena Anna Rita, Dews Michael, Baserga Renato, Sacchi Ada, Cooperative transformation of 32D cells by the combined expression of IRS-1 and V-Ha-Ras, 10.1038/sj.onc.1203664
  4. Sun Hongzhi, Baserga Renato, The role of insulin receptor substrate-1 in transformation by v-src, 10.1002/jcp.21352
  5. Valentinis B, IGF-I receptor signalling in transformation and differentiation, 10.1136/mp.54.3.133
  6. Tanaka, Cancer Res., 56, 3391 (1996)
  7. Surmacz, Clin. Cancer Res., 1, 1429 (1995)
  8. D'Ambrosio, Cell Growth & Differ., 6, 557 (1995)
  9. Tanaka S, Wands J R, A carboxy-terminal truncated insulin receptor substrate-1 dominant negative protein reverses the human hepatocellular carcinoma malignant phenotype., 10.1172/jci119016
  10. Chang, Cancer Res., 62, 6035 (2002)
  11. Wu A, Chen J, Baserga R, Nuclear insulin receptor substrate-1 activates promoters of cell cycle progression genes, 10.1038/sj.onc.1210636
  12. Clevers Hans, Wnt/β-Catenin Signaling in Development and Disease, 10.1016/j.cell.2006.10.018
  13. Drakas R., Tu X., Baserga R., Control of cell size through phosphorylation of upstream binding factor 1 by nuclear phosphatidylinositol 3-kinase, 10.1073/pnas.0403328101
  14. Wu An, Sciacca Laura, Baserga Renato, Nuclear translocation of insulin receptor substrate-1 by the insulin receptor in mouse embryo fibroblasts, 10.1002/jcp.10261
  15. Subcellular Localization of IRS-1 in Cell Proliferation and Differentiation, 10.1055/s-2004-814155
  16. Prisco Marco, Santini Francesca, Baffa Raffaele, Liu Mingli, Drakas Robert, Wu An, Baserga Renato, Nuclear Translocation of Insulin Receptor Substrate-1 by the Simian Virus 40 T Antigen and the Activated Type 1 Insulin-like Growth Factor Receptor, 10.1074/jbc.m204658200
  17. Chen Jia, Wu An, Sun Hongzhi, Drakas Robert, Garofalo Cecilia, Cascio Sandra, Surmacz Eva, Baserga Renato, Functional Significance of Type 1 Insulin-like Growth Factor-mediated Nuclear Translocation of the Insulin Receptor Substrate-1 and β-Catenin, 10.1074/jbc.m504516200
  18. Dearth R. K., Cui X., Kim H.-J., Kuiatse I., Lawrence N. A., Zhang X., Divisova J., Britton O. L., Mohsin S., Allred D. C., Hadsell D. L., Lee A. V., Mammary Tumorigenesis and Metastasis Caused by Overexpression of Insulin Receptor Substrate 1 (IRS-1) or IRS-2, 10.1128/mcb.00260-06
  19. Ramocki Nicole M., Wilkins Heather R., Magness Scott T., Simmons James G., Scull Brooks P., Lee Ginny H., McNaughton Kirk K., Lund P. Kay, Insulin Receptor Substrate-1 Deficiency Promotes Apoptosis in the Putative Intestinal Crypt Stem Cell Region, Limits Apcmin/+Tumors, and Regulates Sox9, 10.1210/en.2007-0869
  20. Foster, Cell Growth & Differ., 10, 423 (1999)
  21. Kolligs Frank T., Hu Gang, Dang Chi V., Fearon Eric R., Neoplastic Transformation of RK3E by Mutant β-Catenin Requires Deregulation of Tcf/Lef Transcription but Not Activation of c-mycExpression, 10.1128/mcb.19.8.5696
  22. Giordano Thomas J, Kuick Rork, Thomas Dafydd G, Misek David E, Vinco Michelle, Sanders Donita, Zhu Zhaowen, Ciampi Raffaele, Roh Michael, Shedden Kerby, Gauger Paul, Doherty Gerard, Thompson Norman W, Hanash Samir, Koenig Ronald J, Nikiforov Yuri E, Molecular classification of papillary thyroid carcinoma: distinct BRAF, RAS, and RET/PTC mutation-specific gene expression profiles discovered by DNA microarray analysis, 10.1038/sj.onc.1208822
  23. Polakis Paul, The many ways of Wnt in cancer, 10.1016/j.gde.2006.12.007
  24. Shedden Kerby, Chen Wei, Kuick Rork, Ghosh Debashis, Macdonald James, Cho Kathleen R, Giordano Thomas J, Gruber Stephen B, Fearon Eric R, Taylor Jeremy MG, Hanash Samir, 10.1186/1471-2105-6-26
  25. Wu Rong, Hendrix-Lucas Neali, Kuick Rork, Zhai Yali, Schwartz Donald R., Akyol Aytekin, Hanash Samir, Misek David E., Katabuchi Hidetaka, Williams Bart O., Fearon Eric R., Cho Kathleen R., Mouse Model of Human Ovarian Endometrioid Adenocarcinoma Based on Somatic Defects in the Wnt/β-Catenin and PI3K/Pten Signaling Pathways, 10.1016/j.ccr.2007.02.016
  26. Kolligs, Genes Dev., 14, 1319 (2000)
  27. Li X, Deng W, Lobo-Ruppert S M, Ruppert J M, Gli1 acts through Snail and E-cadherin to promote nuclear signaling by β-catenin, 10.1038/sj.onc.1210241
  28. Louro, Cancer Res., 62, 5867 (2002)
  29. Herbst Andreas, Bommer Guido T., Kriegl Lydia, Jung Andreas, Behrens Andrea, Csanadi Endy, Gerhard Markus, Bolz Christian, Riesenberg Rainer, Zimmermann Wolfgang, Dietmaier Wolfgang, Wolf Isabella, Brabletz Thomas, Göke Burkhard, Kolligs Frank T., ITF-2 Is Disrupted via Allelic Loss of Chromosome 18q21, and ITF-2B Expression Is Lost at the Adenoma-Carcinoma Transition, 10.1053/j.gastro.2009.04.049
  30. Batlle Eduard, Bacani Julinor, Begthel Harry, Jonkeer Suzanne, Gregorieff Alexander, van de Born Maaike, Malats Núria, Sancho Elena, Boon Elles, Pawson Tony, Gallinger Steven, Pals Steven, Clevers Hans, EphB receptor activity suppresses colorectal cancer progression, 10.1038/nature03626
  31. Kolligs Frank T., Nieman Marvin T., Winer Ira, Hu Gang, Van Mater David, Feng Ying, Smith Ian M., Wu Rong, Zhai Yali, Cho Kathleen R., Fearon Eric R., ITF-2, a downstream target of the Wnt/TCF pathway, is activated in human cancers with β-catenin defects and promotes neoplastic transformation, 10.1016/s1535-6108(02)00035-1
  32. Coghlan Matthew P, Culbert Ainsley A, Cross Darren AE, Corcoran Stacey L, Yates John W, Pearce Nigel J, Rausch Oliver L, Murphy Gregory J, Carter Paul S, Roxbee Cox Lynne, Mills David, Brown Murray J, Haigh David, Ward Robert W, Smith David G, Murray Kenneth J, Reith Alastair D, Holder Julie C, Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription, 10.1016/s1074-5521(00)00025-9
  33. van de Wetering Marc, Sancho Elena, Verweij Cornelis, de Lau Wim, Oving Irma, Hurlstone Adam, van der Horn Karin, Batlle Eduard, Coudreuse Damien, Haramis Anna-Pavlina, Tjon-Pon-Fong Menno, Moerer Petra, van den Born Maaike, Soete Gwen, Pals Steven, Eilers Martin, Medema Rene, Clevers Hans, The β-Catenin/TCF-4 Complex Imposes a Crypt Progenitor Phenotype on Colorectal Cancer Cells, 10.1016/s0092-8674(02)01014-0
  34. Städeli Reto, Hoffmans Raymond, Basler Konrad, Transcription under the Control of Nuclear Arm/β-Catenin, 10.1016/j.cub.2006.04.019
  35. Hatzis P., van der Flier L. G., van Driel M. A., Guryev V., Nielsen F., Denissov S., Nijman I. J., Koster J., Santo E. E., Welboren W., Versteeg R., Cuppen E., van de Wetering M., Clevers H., Stunnenberg H. G., Genome-Wide Pattern of TCF7L2/TCF4 Chromatin Occupancy in Colorectal Cancer Cells, 10.1128/mcb.02175-07
  36. Easton John B., Kurmasheva Raushan T., Houghton Peter J., IRS-1: Auditing the effectiveness of mTOR inhibitors, 10.1016/j.ccr.2006.02.027
  37. Shah O.Jameel, Wang Zhiyong, Hunter Tony, Inappropriate Activation of the TSC/Rheb/mTOR/S6K Cassette Induces IRS1/2 Depletion, Insulin Resistance, and Cell Survival Deficiencies, 10.1016/j.cub.2004.08.026
  38. Shi Bin, Sepp-Lorenzino Laura, Prisco Marco, Linsley Peter, deAngelis Tiziana, Baserga Renato, Micro RNA 145 Targets the Insulin Receptor Substrate-1 and Inhibits the Growth of Colon Cancer Cells, 10.1074/jbc.m702806200
  39. Shi Bin, Prisco Marco, Calin George, Liu Chang-gong, Russo Giuseppe, Giordano Antonio, Baserga Renato, Expression profiles of micro RNA in proliferating and differentiating 32D murine myeloid cells, 10.1002/jcp.20613
  40. Feng Y., Bommer G. T., Zhai Y., Akyol A., Hinoi T., Winer I., Lin H. V., Cadigan K. M., Cho K. R., Fearon E. R., Drosophila split ends Homologue SHARP Functions as a Positive Regulator of Wnt/ -Catenin/T-Cell Factor Signaling in Neoplastic Transformation, 10.1158/0008-5472.can-06-2314
  41. Feng, Cancer Res., 63, 8726 (2003)
  42. Yochum G. S., Cleland R., Goodman R. H., A Genome-Wide Screen for  -Catenin Binding Sites Identifies a Downstream Enhancer Element That Controls c-Myc Gene Expression, 10.1128/mcb.00744-08
  43. Kim Tae Hoon, Abdullaev Ziedulla K., Smith Andrew D., Ching Keith A., Loukinov Dmitri I., Green Roland D., Zhang Michael Q., Lobanenkov Victor V., Ren Bing, Analysis of the Vertebrate Insulator Protein CTCF-Binding Sites in the Human Genome, 10.1016/j.cell.2006.12.048
  44. Barker N., The chromatin remodelling factor Brg-1 interacts with beta-catenin to promote target gene activation, 10.1093/emboj/20.17.4935
  45. Sakatani T., Loss of Imprinting of Igf2 Alters Intestinal Maturation and Tumorigenesis in Mice, 10.1126/science.1108080
  46. Prokunina-Olsson Ludmila, Welch Cullan, Hansson Ola, Adhikari Neeta, Scott Laura J., Usher Nicolle, Tong Maurine, Sprau Andrew, Swift Amy, Bonnycastle Lori L., Erdos Michael R., He Zhi, Saxena Richa, Harmon Brennan, Kotova Olga, Hoffman Eric P., Altshuler David, Groop Leif, Boehnke Michael, Collins Francis S., Hall Jennifer L., Tissue-specific alternative splicing of TCF7L2, 10.1093/hmg/ddp321
  47. Hovanes Karine, Li Tony W.H., Munguia Jesus E., Truong Trung, Milovanovic Tatjana, Lawrence Marsh J., Holcombe Randall F., Waterman Marian L., 10.1038/88264
  48. Roose J., Synergy Between Tumor Suppressor APC and the -Catenin-Tcf4 Target Tcf1, 10.1126/science.285.5435.1923
  49. Clevers Hans, Korinek Vladimir, Barker Nick, Moerer Petra, van Donselaar Elly, Huls Gerwin, Peters Peter J., 10.1038/1270
  50. Tang W., Dodge M., Gundapaneni D., Michnoff C., Roth M., Lum L., A genome-wide RNAi screen for Wnt/ -catenin pathway components identifies unexpected roles for TCF transcription factors in cancer, 10.1073/pnas.0804709105
  51. Araki Eiichi, Lipes Myra A., Patti Mary-Elizabeth, Brüning Jens Claus, Haag III Burritt, Johnson Randall S., Kahn C. Ronald, Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene, 10.1038/372186a0
  52. Ma Z., Gibson S. L., Byrne M. A., Zhang J., White M. F., Shaw L. M., Suppression of Insulin Receptor Substrate 1 (IRS-1) Promotes Mammary Tumor Metastasis, 10.1128/mcb.01032-06
  53. Cui H., Loss of IGF2 Imprinting: A Potential Marker of Colorectal Cancer Risk, 10.1126/science.1080902
  54. Dearth Robert K., Cui Xiaojiang, Kim Hyun-Jung, Hadsell Darryl L., Lee Adrian V., Oncogenic Transformation by the Signaling Adaptor Proteins Insulin Receptor Substrate (IRS)-1 and IRS-2, 10.4161/cc.6.6.4035
  55. Tseng Yu-Hua, Ueki Kohjiro, Kriauciunas Kristina M., Kahn C. Ronald, Differential Roles of Insulin Receptor Substrates in the Anti-apoptotic Function of Insulin-like Growth Factor-1 and Insulin, 10.1074/jbc.m202932200
  56. Hassan, Cancer Res., 60, 1070 (2000)